Pillstats
Rx only · Tablet, Orally Disintegrating · Oral

Methylphenidate

Brands: Cotempla Xr-Odt · Methylphenidate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06BA04
RxCUI (US)6901
US makers1 labelers
Packages3
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$5.17$10.35$15.52$20.69Dec 2025Feb 2026Apr 2026
$17.991
Latest avg · Apr 1, 2026
+5%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.2K4.4K6.6K8.8K2025 Q12025 Q22025 Q32025 Q42026 Q1
6.0K
Rx · 2026 Q1
219K
Units dispensed
-22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Neos Therapeutics, LPunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.